Company / Cash per Share
AGIOS PHARMACEUTICALS, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.56
FY2025
5-year range
$1.36 / $3.36
FY2021-FY2025
Trend
+14.4%
vs FY2024
Sector context
#124 of 205
Health Care
What the data says
At $1.56, AGIOS PHARMACEUTICALS, INC.'s cash per share ranks #124 of 205 in the Health Care sector. Cash per Share returned to growth in FY2025 after 3 years of decline, reaching $1.56.
Based on SEC 10-K filings.
1.56 in FY2025 with a 5-year CAGR of -3.5%.
Declined from $1.60 to $1.56 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -15.3%
- 5-Year CAGR
- -3.5%
- 10-Year CAGR
- -
Sector benchmark
#124 of 205 in Health CareTop 60% of 205This company $1.56 Sector average $67.98
▼
-97.7% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 14.4% year-over-year.
- Ranks #124 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
- Lowest cash per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | +14.4% |
| FY2024 | $1.36 | -15.0% |
| FY2023 | $1.60 | -37.5% |
| FY2022 | $2.56 | -23.7% |
| FY2021 | $3.36 | +80.4% |
| FY2020 | $1.86 | +34.0% |
| FY2019 | $1.39 | -3.7% |
| FY2018 | $1.44 | -40.7% |
| FY2017 | $2.43 | -42.9% |
| FY2016 | $4.26 | +121.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026